Stocks Crushing the Market, 6 Climb to Fresh Highs. Travere Therapeutics, Inc. (NASDAQ:TVTX) is one of the top performers on ...

If approved, FILSPARI would be the first medication indicated for FSGS, a rare and serious kidney disorder driven by ...

Travere Therapeutics, Inc. is rated Buy with FILSPARI’s robust growth, FDA approval, and key milestones ahead. Click here to ...

Travere (TVTX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...

Learn more about whether ADMA Biologics, Inc. or Travere Therapeutics, Inc. is a better investment based on AAII's A+ ...

Travere Therapeutics, Inc. (TVTX) shares are trading higher on Wednesday after the company announced that it was informed by ...

Learn more about whether Alvotech or Travere Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, ...

An announcement from Travere Therapeutics ( ($TVTX) ) is now available. On September 10, 2025, Travere Therapeutics announced that the FDA has ...

Detailed price information for Travere Therapeutics Inc (TVTX-Q) from The Globe and Mail including charting and trades.

Shares of Travere Therapeutics shot higher Wednesday after the FDA eliminated a key step to a new approval for its drug, ...

CarMax reports that the Chevrolet Traverse excels in space and tech, while the Honda Pilot offers superior driving experience ...